![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Antiviral Activity of MK-1439, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), In Treatment-Naïve HIV-Infected Patients
|
|
|
Reported by Jules Levin
CROI Atlanta March 3-6 2013
Matt S. Anderson1, Jocelyn Gilmartin1, Martine Robberechts2, Inge De Lepeleire2, Ernestina Tetteh1, Ying Guo1, Dirk Schurmann3, Frank Wagner4, John A. Wagner1, Joan R. Butterton1
1Merck Sharp & Dohme Corp., Whitehouse Station, NJ USA
2MSD Belgium, Brussels, Belgium
3Charite - Universitatsmedizin Berlin, Berlin, Germany
4Charite - Research Organisation, Berlin, Germany
![CROI1.gif](../images/030513/030512-3/CROI1.gif)
![CROI2.gif](../images/030513/030512-3/CROI2.gif)
![CROI3.gif](../images/030513/030512-3/CROI3.gif)
![CROI4.gif](../images/030513/030512-3/CROI4.gif)
![CROI5.gif](../images/030513/030512-3/CROI5.gif)
![CROI6.gif](../images/030513/030512-3/CROI6.gif)
![CROI7.gif](../images/030513/030512-3/CROI7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|